Company profile
Ticker
KAPA
Exchange
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
DRVW 2022 Ltd
SEC CIK
IRS number
462993314
Analyst ratings and price targets
Latest filings (excl ownership)
8-K
Other Events
10 Oct 24
8-K
Entry into a Material Definitive Agreement
4 Oct 24
S-8
Registration of securities for employees
27 Sep 24
8-K
Entry into a Material Definitive Agreement
27 Sep 24
8-K
Kairos Pharma Enters Agreement with PreCheck Health Services
24 Sep 24
8-K
Kairos Pharma Closing of $6.2 Million Initial Public Offering
17 Sep 24
424B4
Prospectus supplement with pricing info
17 Sep 24
EFFECT
Notice of effectiveness
17 Sep 24
CERT
Certification of approval for exchange listing
12 Sep 24
8-A12B
Registration of securities on exchange
12 Sep 24
News
EF Hutton Initiates Coverage On Kairos Pharma with Buy Rating, Announces Price Target of $9
14 Oct 24
12 Health Care Stocks Moving In Monday's After-Market Session
7 Oct 24
12 Health Care Stocks Moving In Wednesday's After-Market Session
2 Oct 24
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
2 Oct 24
12 Health Care Stocks Moving In Thursday's Intraday Session
26 Sep 24
Press releases
Kairos Pharma (NYSEAmerican: KAPA): Advancing New Strategies to Overcome Cancer Treatment Challenges
14 Oct 24
Kairos Pharma to Participate in a Fireside Chat at the 2024 Maxim Healthcare Virtual Summit
9 Oct 24
Kairos Pharma Enters Agreement with PreCheck Health Services to Develop Biomarkers to Identify Patients Responsive to ENV105 to Target Cancer Drug Resistance in Prostate and Lung Cancer Patients
24 Sep 24
Kairos Pharma Closing of $6.2 Million Initial Public Offering
17 Sep 24
Kairos Pharma Prices $6.2 Million Initial Public Offering
16 Sep 24